Correlation Between Emergent Biosolutions and Corcept Therapeutics

Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Corcept Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Corcept Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emergent Biosolutions and Corcept Therapeutics Incorporated, you can compare the effects of market volatilities on Emergent Biosolutions and Corcept Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Corcept Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Corcept Therapeutics.

Diversification Opportunities for Emergent Biosolutions and Corcept Therapeutics

0.58

Correlation Coefficient

Emergent Biosolutions  Corcept Therapeutics

Very weak diversification

The 3 months correlation between Emergent and Corcept is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Corcept Therapeutics Incorpora in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corcept Therapeutics and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Corcept Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corcept Therapeutics has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Corcept Therapeutics go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Corcept Therapeutics

Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 2.21 times more return on investment than Corcept Therapeutics. However, Emergent Biosolutions is 2.21 times more volatile than Corcept Therapeutics Incorporated. It trades about 0.1 of its potential returns per unit of risk. Corcept Therapeutics Incorporated is currently generating about 0.11 per unit of risk. If you would invest  606.00  in Emergent Biosolutions on September 21, 2024 and sell it today you would earn a total of  204.00  from holding Emergent Biosolutions or generate 33.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Emergent Biosolutions  vs.  Corcept Therapeutics Incorpora

Emergent Biosolutions

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.

Corcept Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Corcept Therapeutics Incorporated are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Corcept Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Emergent Biosolutions and Corcept Therapeutics

The main advantage of trading using opposite Emergent Biosolutions and Corcept Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Corcept Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corcept Therapeutics will offset losses from the drop in Corcept Therapeutics' long position.

The idea behind Emergent Biosolutions and Corcept Therapeutics Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.